These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17136952)

  • 1. The airway pathophysiology of COPD: implications for treatment.
    Rodríguez-Roisin R
    COPD; 2005 Jun; 2(2):253-62. PubMed ID: 17136952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD, a multicomponent disease: implications for management.
    Agusti AG
    Respir Med; 2005 Jun; 99(6):670-82. PubMed ID: 15878483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucociliary dysfunction in COPD: effect of current pharmacotherapeutic options.
    Rogers DF
    Pulm Pharmacol Ther; 2005; 18(1):1-8. PubMed ID: 15607121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
    Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
    Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD.
    Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM
    Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW; Nelson LS; Lydick E; Soriano J; Yood MU; Davis KJ
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects.
    Malerba M; Radaeli A; Morjaria JB
    Drug Discov Today; 2012 May; 17(9-10):496-504. PubMed ID: 22119310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.
    Chen AM; Bollmeier SG; Finnegan PM
    Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and future therapies for airway mucus hypersecretion.
    Barnes PJ
    Novartis Found Symp; 2002; 248():237-49; discussion 249-53, 277-82. PubMed ID: 12568498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pharmacoeconomic profile of COPD patients with FEV1 50--60% predicted: pilot study on the impact of the extended indication of ICS/LABA.
    Dal Negro RW; Bonadiman L; Turati C; Turco P
    Ther Adv Respir Dis; 2009 Apr; 3(2):51-8. PubMed ID: 19443518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M; Biddle AK; Stearns SC
    Clin Ther; 2008; 30 Spec No():1003-16. PubMed ID: 18640475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing stable COPD in 2009: incorporating results from recent clinical studies into a goal-directed approach for clinicians.
    Rubins JB; Raci E; Kunisaki KM
    Postgrad Med; 2009 Jan; 121(1):104-12. PubMed ID: 19179818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in chronic obstructive pulmonary disease.
    Barnes PJ
    Trans Med Soc Lond; 2002-2003; 119():41-51. PubMed ID: 17184031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future perspectives in COPD.
    Celli B; Goldstein R; Jardim J; Knobil K
    Respir Med; 2005 Dec; 99 Suppl B():S41-8. PubMed ID: 16256325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
    Andò F; Ruggeri P; Girbino G; Cazzola M
    Respir Med; 2008 Jun; 102(6):815-8. PubMed ID: 18343646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COPD: an inflammatory disease of the airways?].
    Magnussen H
    Pneumologie; 2004 May; 58(5):320-4. PubMed ID: 15162257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis: a potentially critical part of remodelling in chronic airway diseases?
    Walters EH; Reid D; Soltani A; Ward C
    Pharmacol Ther; 2008 Apr; 118(1):128-37. PubMed ID: 18358536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.